title: Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding.
abstract: BACKGROUND
  Nomadic populations are often isolated and have difficulty accessing health care, leading to increased morbidity and mortality. Although Nigeria has one of the highest tuberculosis (TB) burdens in Africa, case detection rates remain relatively low.
  
  
  METHODS
  Active case finding for TB among nomadic populations was implemented over a 2-year period in Adamawa State. A total of 378 community screening days were organised with local leaders; community volunteers provided treatment support. Xpert(®) MTB/RIF was available for nomads with negative smear results.
  
  
  RESULTS
  Through active case finding, 96 376 nomads were verbally screened, yielding 1310 bacteriologically positive patients. The number of patients submitting sputum for smear microscopy statewide increased by 112% compared with the 2 years before the intervention. New smear-positive notifications increased by 49.5%, while notifications of all forms of TB increased by 24.5% compared with expected notifications based on historical trends. Nomads accounted for respectively 31.4% and 26.0% of all smear-positive and all forms TB notifications. Pre-treatment loss to follow-up and treatment outcomes were similar among nomads and non-nomads.
  
  
  CONCLUSIONS
  Nomads in Nigeria have high TB rates, and active case-finding approaches may be useful in identifying and successfully treating them. Large-scale interventions in vulnerable populations can improve TB case detection.
authors: Adamawa State Tuberculosis and Leprosy Control Programme, Yola, Nigeria; KNCV TB CARE 1, Abuja, Nigeria.
authors: S
authors: S
authors: John
authors: KNCV TB CARE 1, Abuja, Nigeria.
authors: M
authors: M
authors: Gidado
authors: Netherlands Leprosy Relief, Jos, Nigeria.
authors: T
authors: T
authors: Dahiru
authors: University of Alberta, Edmonton, Alberta, Canada.
authors: A
authors: A
authors: Fanning
authors: Stop TB Partnership, Geneva, Switzerland.
authors: A J
authors: AJ
authors: Codlin
authors: Stop TB Partnership, Geneva, Switzerland.
authors: J
authors: J
authors: Creswell
mesh_terms: D060085:Coinfection / Q000175:diagnosis; D005260:Female; D015658:HIV Infections / Q000175:diagnosis; D006801:Humans; D008297:Male; D008853:Microscopy; D009169:Mycobacterium tuberculosis; D009549:Nigeria / Q000453:epidemiology; D012293:Rifampin / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D014171:Transients and Migrants / Q000706:statistics & numerical data*; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000188:drug therapy / Q000208:ethnology*; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy / Q000208:ethnology*
chemical_list: D012293:Rifampin